CLP 2024 – Saturday: Plenary | Finale | Business Meeting | Yesterday

Psychedelics: The Saturday Plenary

An evolving drug class with a controversial history in psychiatric care enjoying a resurgence

Come learn about one of the hottest topics in the field at today’s plenary session, The Future of Psychedelic Therapeutics in C-L Psychiatry: Practical, Ethical, and ‎Clinical Perspectives.

This evolving drug class with an ‎interesting and controversial history is now enjoying a resurgence in clinical interest and ‎advocacy for wider applications in psychiatric care.

ACLP past president (2010-2011), John Shuster, Jr, MD, FACLP, will moderate an informative and dynamic conversation.

Speakers will address considerations such as the potential medicinal and medical benefits in balance with ‎immediate and longitudinal toxicologic risks; the use of psychedelic therapies in patients with serious medical illness; and ethical considerations of ‎psychedelic therapeutics in the context of the current evidence base.

Also, learn how to navigate emerging legal and ethical issues, including those related to standards of care, informed ‎consent, conflicts between federal and state law, the right to try, and liability insurance coverage.

This session will bring you to the forefront of this rapidly-evolving area!

Speakers are:

Jacob Appel, MD, JD, DFAPA, professor, Psychiatry, Icahn School of Medicine at Mount Sinai.
Roxanne Sholevar, MD, staff psychiatrist, Department of Psychosocial Oncology & Palliative Care, Dana-Farber Cancer Institute.
J.J. Rasimas, PhD, MD, FAACT, FACLP, FACMT, FACPsych, medical director, C-L Psychiatry Service & Fellowship, Hennepin County Medical Center.

Moderator is:

John Shuster, Jr., MD, FACLP, chief medical officer, MindCare Solutions.